APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rotavirus Infections Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rotavirus Infections Drug Market Analysis and Forecast 2026-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchRotavirus Infections Drug Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Rotavirus Infections Drug Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Rotavirus Infections Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rotavirus Infections Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Rotavirus Infections Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Rotavirus Infections Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Rotavirus Infections Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rotavirus Infections Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rotavirus Infections Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rotavirus Infections Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Rotavirus Infections Drug include Wuhan Institute of Biological Products Co Ltd, Beijing Minhai Biotechnology Co Ltd, UMN Pharma Inc, Serum Institute of India Ltd, Nanotherapeutics Inc, Medicago Inc, Curevac AG, Biological E Ltd and Bharat Biotech International Ltd, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Rotavirus Infections Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rotavirus Infections Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Rotavirus Infections Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rotavirus Infections Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rotavirus Infections Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Rotavirus Infections Drug sales, projected growth trends, production technology, application and end-user industry.

Rotavirus Infections Drug Segment by Company

Wuhan Institute of Biological Products Co Ltd

Beijing Minhai Biotechnology Co Ltd

UMN Pharma Inc

Serum Institute of India Ltd

Nanotherapeutics Inc

Medicago Inc

Curevac AG

Biological E Ltd

Bharat Biotech International Ltd

Rotavirus Infections Drug Segment by Type

UMN-2001

RV-625

RV-3BB

Rotavac-5C

Others

Rotavirus Infections Drug Segment by Application

Clinic

Hospital

Others

Rotavirus Infections Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rotavirus Infections Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rotavirus Infections Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rotavirus Infections Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Rotavirus Infections Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Rotavirus Infections Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rotavirus Infections Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rotavirus Infections Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. UMN-2001 Major Manufacturers Table 3. RV-625 Major Manufacturers Table 4. RV-3BB Major Manufacturers Table 5. Rotavac-5C Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Rotavirus Infections Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Clinic Major Manufacturers Table 9. Hospital Major Manufacturers Table 10. Others Major Manufacturers Table 11. Rotavirus Infections Drug Industry Trends Table 12. Rotavirus Infections Drug Industry Drivers Table 13. Rotavirus Infections Drug Industry Opportunities and Challenges Table 14. Rotavirus Infections Drug Industry Restraints Table 15. Global Rotavirus Infections Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Rotavirus Infections Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Rotavirus Infections Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Rotavirus Infections Drug Revenue Market Share by Region (2021-2026) Table 19. Global Rotavirus Infections Drug Revenue Market Share by Region (2027-2032) Table 20. Global Rotavirus Infections Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 21. Global Rotavirus Infections Drug Sales by Region (2021-2026) & (k units) Table 22. Global Rotavirus Infections Drug Sales by Region (2027-2032) & (k units) Table 23. Global Rotavirus Infections Drug Sales Market Share by Region (2021-2026) Table 24. Global Rotavirus Infections Drug Sales Market Share by Region (2027-2032) Table 25. Global Rotavirus Infections Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Rotavirus Infections Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Rotavirus Infections Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Rotavirus Infections Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Rotavirus Infections Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 30. Global Rotavirus Infections Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Rotavirus Infections Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Rotavirus Infections Drug Manufacturers, Product Type & Application Table 33. Global Rotavirus Infections Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Rotavirus Infections Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Rotavirus Infections Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Rotavirus Infections Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Rotavirus Infections Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Rotavirus Infections Drug Revenue Market Share by Type (2021-2026) Table 40. Global Rotavirus Infections Drug Revenue Market Share by Type (2027-2032) Table 41. Global Rotavirus Infections Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 42. Global Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 43. Global Rotavirus Infections Drug Sales by Type (2027-2032) & (k units) Table 44. Global Rotavirus Infections Drug Sales Market Share by Type (2021-2026) Table 45. Global Rotavirus Infections Drug Sales Market Share by Type (2027-2032) Table 46. Global Rotavirus Infections Drug Price by Type (2021-2026) & (US$/unit) Table 47. Global Rotavirus Infections Drug Price by Type (2027-2032) & (US$/unit) Table 48. Global Rotavirus Infections Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Rotavirus Infections Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Rotavirus Infections Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Rotavirus Infections Drug Revenue Market Share by Application (2021-2026) Table 52. Global Rotavirus Infections Drug Revenue Market Share by Application (2027-2032) Table 53. Global Rotavirus Infections Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 54. Global Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 55. Global Rotavirus Infections Drug Sales by Application (2027-2032) & (k units) Table 56. Global Rotavirus Infections Drug Sales Market Share by Application (2021-2026) Table 57. Global Rotavirus Infections Drug Sales Market Share by Application (2027-2032) Table 58. Global Rotavirus Infections Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Rotavirus Infections Drug Price by Application (2027-2032) & (US$/unit) Table 60. Wuhan Institute of Biological Products Co Ltd Company Information Table 61. Wuhan Institute of Biological Products Co Ltd Business Overview Table 62. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 63. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Portfolio Table 64. Wuhan Institute of Biological Products Co Ltd Recent Development Table 65. Beijing Minhai Biotechnology Co Ltd Company Information Table 66. Beijing Minhai Biotechnology Co Ltd Business Overview Table 67. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Portfolio Table 69. Beijing Minhai Biotechnology Co Ltd Recent Development Table 70. UMN Pharma Inc Company Information Table 71. UMN Pharma Inc Business Overview Table 72. UMN Pharma Inc Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. UMN Pharma Inc Rotavirus Infections Drug Product Portfolio Table 74. UMN Pharma Inc Recent Development Table 75. Serum Institute of India Ltd Company Information Table 76. Serum Institute of India Ltd Business Overview Table 77. Serum Institute of India Ltd Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Serum Institute of India Ltd Rotavirus Infections Drug Product Portfolio Table 79. Serum Institute of India Ltd Recent Development Table 80. Nanotherapeutics Inc Company Information Table 81. Nanotherapeutics Inc Business Overview Table 82. Nanotherapeutics Inc Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Nanotherapeutics Inc Rotavirus Infections Drug Product Portfolio Table 84. Nanotherapeutics Inc Recent Development Table 85. Medicago Inc Company Information Table 86. Medicago Inc Business Overview Table 87. Medicago Inc Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Medicago Inc Rotavirus Infections Drug Product Portfolio Table 89. Medicago Inc Recent Development Table 90. Curevac AG Company Information Table 91. Curevac AG Business Overview Table 92. Curevac AG Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Curevac AG Rotavirus Infections Drug Product Portfolio Table 94. Curevac AG Recent Development Table 95. Biological E Ltd Company Information Table 96. Biological E Ltd Business Overview Table 97. Biological E Ltd Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Biological E Ltd Rotavirus Infections Drug Product Portfolio Table 99. Biological E Ltd Recent Development Table 100. Bharat Biotech International Ltd Company Information Table 101. Bharat Biotech International Ltd Business Overview Table 102. Bharat Biotech International Ltd Rotavirus Infections Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Bharat Biotech International Ltd Rotavirus Infections Drug Product Portfolio Table 104. Bharat Biotech International Ltd Recent Development Table 105. North America Rotavirus Infections Drug Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Rotavirus Infections Drug Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 108. North America Rotavirus Infections Drug Sales by Type (2027-2032) & (k units) Table 109. North America Rotavirus Infections Drug Sales Price by Type (2021-2026) & (US$/unit) Table 110. North America Rotavirus Infections Drug Sales Price by Type (2027-2032) & (US$/unit) Table 111. North America Rotavirus Infections Drug Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Rotavirus Infections Drug Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 114. North America Rotavirus Infections Drug Sales by Application (2027-2032) & (k units) Table 115. North America Rotavirus Infections Drug Sales Price by Application (2021-2026) & (US$/unit) Table 116. North America Rotavirus Infections Drug Sales Price by Application (2027-2032) & (US$/unit) Table 117. North America Rotavirus Infections Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Rotavirus Infections Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. North America Rotavirus Infections Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. North America Rotavirus Infections Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 121. North America Rotavirus Infections Drug Sales by Country (2021-2026) & (k units) Table 122. North America Rotavirus Infections Drug Sales by Country (2027-2032) & (k units) Table 123. North America Rotavirus Infections Drug Sales Price by Country (2021-2026) & (US$/unit) Table 124. North America Rotavirus Infections Drug Sales Price by Country (2027-2032) & (US$/unit) Table 125. United States Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 126. Canada Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 127. Mexico Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 128. Europe Rotavirus Infections Drug Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Rotavirus Infections Drug Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 131. Europe Rotavirus Infections Drug Sales by Type (2027-2032) & (k units) Table 132. Europe Rotavirus Infections Drug Sales Price by Type (2021-2026) & (US$/unit) Table 133. Europe Rotavirus Infections Drug Sales Price by Type (2027-2032) & (US$/unit) Table 134. Europe Rotavirus Infections Drug Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Rotavirus Infections Drug Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 137. Europe Rotavirus Infections Drug Sales by Application (2027-2032) & (k units) Table 138. Europe Rotavirus Infections Drug Sales Price by Application (2021-2026) & (US$/unit) Table 139. Europe Rotavirus Infections Drug Sales Price by Application (2027-2032) & (US$/unit) Table 140. Europe Rotavirus Infections Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Rotavirus Infections Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Europe Rotavirus Infections Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Europe Rotavirus Infections Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 144. Europe Rotavirus Infections Drug Sales by Country (2021-2026) & (k units) Table 145. Europe Rotavirus Infections Drug Sales by Country (2027-2032) & (k units) Table 146. Europe Rotavirus Infections Drug Sales Price by Country (2021-2026) & (US$/unit) Table 147. Europe Rotavirus Infections Drug Sales Price by Country (2027-2032) & (US$/unit) Table 148. Germany Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 149. France Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 150. U.K. Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 151. Italy Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 152. Russia Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 153. Spain Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 154. Netherlands Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 155. Switzerland Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 156. Sweden Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 157. Poland Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 158. China Rotavirus Infections Drug Revenue by Type (2021-2026) & (US$ Million) Table 159. China Rotavirus Infections Drug Revenue by Type (2027-2032) & (US$ Million) Table 160. China Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 161. China Rotavirus Infections Drug Sales by Type (2027-2032) & (k units) Table 162. China Rotavirus Infections Drug Sales Price by Type (2021-2026) & (US$/unit) Table 163. China Rotavirus Infections Drug Sales Price by Type (2027-2032) & (US$/unit) Table 164. China Rotavirus Infections Drug Revenue by Application (2021-2026) & (US$ Million) Table 165. China Rotavirus Infections Drug Revenue by Application (2027-2032) & (US$ Million) Table 166. China Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 167. China Rotavirus Infections Drug Sales by Application (2027-2032) & (k units) Table 168. China Rotavirus Infections Drug Sales Price by Application (2021-2026) & (US$/unit) Table 169. China Rotavirus Infections Drug Sales Price by Application (2027-2032) & (US$/unit) Table 170. Asia Rotavirus Infections Drug Revenue by Type (2021-2026) & (US$ Million) Table 171. Asia Rotavirus Infections Drug Revenue by Type (2027-2032) & (US$ Million) Table 172. Asia Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 173. Asia Rotavirus Infections Drug Sales by Type (2027-2032) & (k units) Table 174. Asia Rotavirus Infections Drug Sales Price by Type (2021-2026) & (US$/unit) Table 175. Asia Rotavirus Infections Drug Sales Price by Type (2027-2032) & (US$/unit) Table 176. Asia Rotavirus Infections Drug Revenue by Application (2021-2026) & (US$ Million) Table 177. Asia Rotavirus Infections Drug Revenue by Application (2027-2032) & (US$ Million) Table 178. Asia Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 179. Asia Rotavirus Infections Drug Sales by Application (2027-2032) & (k units) Table 180. Asia Rotavirus Infections Drug Sales Price by Application (2021-2026) & (US$/unit) Table 181. Asia Rotavirus Infections Drug Sales Price by Application (2027-2032) & (US$/unit) Table 182. Asia Rotavirus Infections Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Asia Rotavirus Infections Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Asia Rotavirus Infections Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Asia Rotavirus Infections Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 186. Asia Rotavirus Infections Drug Sales by Country (2021-2026) & (k units) Table 187. Asia Rotavirus Infections Drug Sales by Country (2027-2032) & (k units) Table 188. Asia Rotavirus Infections Drug Sales Price by Country (2021-2026) & (US$/unit) Table 189. Asia Rotavirus Infections Drug Sales Price by Country (2027-2032) & (US$/unit) Table 190. Japan Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 191. South Korea Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 192. India Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 193. Australia Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 194. Taiwan Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 195. Southeast Asia Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 196. SAMEA Rotavirus Infections Drug Revenue by Type (2021-2026) & (US$ Million) Table 197. SAMEA Rotavirus Infections Drug Revenue by Type (2027-2032) & (US$ Million) Table 198. SAMEA Rotavirus Infections Drug Sales by Type (2021-2026) & (k units) Table 199. SAMEA Rotavirus Infections Drug Sales by Type (2027-2032) & (k units) Table 200. SAMEA Rotavirus Infections Drug Sales Price by Type (2021-2026) & (US$/unit) Table 201. SAMEA Rotavirus Infections Drug Sales Price by Type (2027-2032) & (US$/unit) Table 202. SAMEA Rotavirus Infections Drug Revenue by Application (2021-2026) & (US$ Million) Table 203. SAMEA Rotavirus Infections Drug Revenue by Application (2027-2032) & (US$ Million) Table 204. SAMEA Rotavirus Infections Drug Sales by Application (2021-2026) & (k units) Table 205. SAMEA Rotavirus Infections Drug Sales by Application (2027-2032) & (k units) Table 206. SAMEA Rotavirus Infections Drug Sales Price by Application (2021-2026) & (US$/unit) Table 207. SAMEA Rotavirus Infections Drug Sales Price by Application (2027-2032) & (US$/unit) Table 208. SAMEA Rotavirus Infections Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. SAMEA Rotavirus Infections Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. SAMEA Rotavirus Infections Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. SAMEA Rotavirus Infections Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 212. SAMEA Rotavirus Infections Drug Sales by Country (2021-2026) & (k units) Table 213. SAMEA Rotavirus Infections Drug Sales by Country (2027-2032) & (k units) Table 214. SAMEA Rotavirus Infections Drug Sales Price by Country (2021-2026) & (US$/unit) Table 215. SAMEA Rotavirus Infections Drug Sales Price by Country (2027-2032) & (US$/unit) Table 216. Brazil Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 217. Argentina Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 218. Chile Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 219. Colombia Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 220. Peru Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 221. Saudi Arabia Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 222. Israel Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 223. UAE Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 224. Turkey Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 225. Iran Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 226. Egypt Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Table 227. Key Raw Materials Table 228. Raw Materials Key Suppliers Table 229. Rotavirus Infections Drug Distributors List Table 230. Rotavirus Infections Drug Customers List Table 231. Research Programs/Design for This Report Table 232. Authors List of This Report Table 233. Secondary Sources Table 234. Primary Sources List of Figures Figure 1. Rotavirus Infections Drug Image Figure 2. Global Rotavirus Infections Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rotavirus Infections Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. UMN-2001 Image Figure 5. RV-625 Image Figure 6. RV-3BB Image Figure 7. Rotavac-5C Image Figure 8. Others Image Figure 9. Global Rotavirus Infections Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Rotavirus Infections Drug Market Size Share 2021 VS 2025 VS 2032 Figure 11. Clinic Image Figure 12. Hospital Image Figure 13. Others Image Figure 14. Global Rotavirus Infections Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Rotavirus Infections Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Rotavirus Infections Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Rotavirus Infections Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Rotavirus Infections Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Rotavirus Infections Drug Sales (2021-2032) & (k units) Figure 20. Global Rotavirus Infections Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 21. Global Rotavirus Infections Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Rotavirus Infections Drug Sales YoY (2021-2032) & (k units) Figure 23. Europe Rotavirus Infections Drug Sales YoY (2021-2032) & (k units) Figure 24. China Rotavirus Infections Drug Sales YoY (2021-2032) & (k units) Figure 25. Asia (Excluding China) Rotavirus Infections Drug Sales YoY (2021-2032) & (k units) Figure 26. South America, Middle East and Africa Rotavirus Infections Drug Sales YoY (2021-2032) & (k units) Figure 27. Global Rotavirus Infections Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Rotavirus Infections Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Rotavirus Infections Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Rotavirus Infections Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Rotavirus Infections Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Rotavirus Infections Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 34. Global Rotavirus Infections Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Rotavirus Infections Drug Sales Market Share by Type (2021-2032) Figure 36. Global Rotavirus Infections Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Rotavirus Infections Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Rotavirus Infections Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Rotavirus Infections Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 40. Global Rotavirus Infections Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Rotavirus Infections Drug Sales Market Share by Application (2021-2032) Figure 42. North America Rotavirus Infections Drug Revenue Share by Type (2021-2032) Figure 43. North America Rotavirus Infections Drug Sales Share by Type (2021-2032) Figure 44. North America Rotavirus Infections Drug Revenue Share by Application (2021-2032) Figure 45. North America Rotavirus Infections Drug Sales Share by Application (2021-2032) Figure 46. North America Rotavirus Infections Drug Revenue Share by Country (2021-2032) Figure 47. North America Rotavirus Infections Drug Sales Share by Country (2021-2032) Figure 48. Europe Rotavirus Infections Drug Revenue Share by Type (2021-2032) Figure 49. Europe Rotavirus Infections Drug Sales Share by Type (2021-2032) Figure 50. Europe Rotavirus Infections Drug Revenue Share by Application (2021-2032) Figure 51. Europe Rotavirus Infections Drug Sales Share by Application (2021-2032) Figure 52. Europe Rotavirus Infections Drug Revenue Share by Country (2021-2032) Figure 53. Europe Rotavirus Infections Drug Sales Share by Country (2021-2032) Figure 54. China Rotavirus Infections Drug Revenue Share by Type (2021-2032) Figure 55. China Rotavirus Infections Drug Sales Share by Type (2021-2032) Figure 56. China Rotavirus Infections Drug Revenue Share by Application (2021-2032) Figure 57. China Rotavirus Infections Drug Sales Share by Application (2021-2032) Figure 58. Asia Rotavirus Infections Drug Revenue Share by Type (2021-2032) Figure 59. Asia Rotavirus Infections Drug Sales Share by Type (2021-2032) Figure 60. Asia Rotavirus Infections Drug Revenue Share by Application (2021-2032) Figure 61. Asia Rotavirus Infections Drug Sales Share by Application (2021-2032) Figure 62. Asia Rotavirus Infections Drug Revenue Share by Country (2021-2032) Figure 63. Asia Rotavirus Infections Drug Sales Share by Country (2021-2032) Figure 64. SAMEA Rotavirus Infections Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA Rotavirus Infections Drug Sales Share by Type (2021-2032) Figure 66. SAMEA Rotavirus Infections Drug Revenue Share by Application (2021-2032) Figure 67. SAMEA Rotavirus Infections Drug Sales Share by Application (2021-2032) Figure 68. SAMEA Rotavirus Infections Drug Revenue Share by Country (2021-2032) Figure 69. SAMEA Rotavirus Infections Drug Sales Share by Country (2021-2032) Figure 70. Rotavirus Infections Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Rotavirus Infections Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • UMN-2001
  • RV-625
  • RV-3BB
  • Rotavac-5C
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Wuhan Institute of Biological Products Co Ltd
  • Beijing Minhai Biotechnology Co Ltd
  • UMN Pharma Inc
  • Serum Institute of India Ltd
  • Nanotherapeutics Inc
  • Medicago Inc
  • Curevac AG
  • Biological E Ltd
  • Bharat Biotech International Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rotavirus Infections Drug Market by Type
  3. 1.2.1 Global Rotavirus Infections Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 UMN-2001
  5. 1.2.3 RV-625
  6. 1.2.4 RV-3BB
  7. 1.2.5 Rotavac-5C
  8. 1.2.6 Others
  9. 1.3 Rotavirus Infections Drug Market by Application
  10. 1.3.1 Global Rotavirus Infections Drug Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Clinic
  12. 1.3.3 Hospital
  13. 1.3.4 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Rotavirus Infections Drug Market Dynamics
  1. 2.1 Rotavirus Infections Drug Industry Trends
  2. 2.2 Rotavirus Infections Drug Industry Drivers
  3. 2.3 Rotavirus Infections Drug Industry Opportunities and Challenges
  4. 2.4 Rotavirus Infections Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Rotavirus Infections Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Rotavirus Infections Drug Revenue by Region
  3. 3.2.1 Global Rotavirus Infections Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rotavirus Infections Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Rotavirus Infections Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Rotavirus Infections Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Rotavirus Infections Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Rotavirus Infections Drug Sales by Region
  9. 3.4.1 Global Rotavirus Infections Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Rotavirus Infections Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Rotavirus Infections Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Rotavirus Infections Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Rotavirus Infections Drug Revenue by Manufacturers
  2. 4.1.1 Global Rotavirus Infections Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Rotavirus Infections Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Rotavirus Infections Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rotavirus Infections Drug Sales by Manufacturers
  6. 4.2.1 Global Rotavirus Infections Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Rotavirus Infections Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Rotavirus Infections Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Rotavirus Infections Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Rotavirus Infections Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Rotavirus Infections Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Rotavirus Infections Drug Manufacturers, Product Type & Application
  13. 4.7 Global Rotavirus Infections Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Rotavirus Infections Drug Market CR5 and HHI
  16. 4.8.2 2025 Rotavirus Infections Drug Tier 1, Tier 2, and Tier 3
5 Rotavirus Infections Drug Market by Type
  1. 5.1 Global Rotavirus Infections Drug Revenue by Type
  2. 5.1.1 Global Rotavirus Infections Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Rotavirus Infections Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Rotavirus Infections Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Rotavirus Infections Drug Sales by Type
  6. 5.2.1 Global Rotavirus Infections Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rotavirus Infections Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Rotavirus Infections Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Rotavirus Infections Drug Price by Type
6 Rotavirus Infections Drug Market by Application
  1. 6.1 Global Rotavirus Infections Drug Revenue by Application
  2. 6.1.1 Global Rotavirus Infections Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Rotavirus Infections Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Rotavirus Infections Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Rotavirus Infections Drug Sales by Application
  6. 6.2.1 Global Rotavirus Infections Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Rotavirus Infections Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Rotavirus Infections Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Rotavirus Infections Drug Price by Application
7 Company Profiles
  1. 7.1 Wuhan Institute of Biological Products Co Ltd
  2. 7.1.1 Wuhan Institute of Biological Products Co Ltd Company Information
  3. 7.1.2 Wuhan Institute of Biological Products Co Ltd Business Overview
  4. 7.1.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Portfolio
  6. 7.1.5 Wuhan Institute of Biological Products Co Ltd Recent Developments
  7. 7.2 Beijing Minhai Biotechnology Co Ltd
  8. 7.2.1 Beijing Minhai Biotechnology Co Ltd Company Information
  9. 7.2.2 Beijing Minhai Biotechnology Co Ltd Business Overview
  10. 7.2.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Portfolio
  12. 7.2.5 Beijing Minhai Biotechnology Co Ltd Recent Developments
  13. 7.3 UMN Pharma Inc
  14. 7.3.1 UMN Pharma Inc Company Information
  15. 7.3.2 UMN Pharma Inc Business Overview
  16. 7.3.3 UMN Pharma Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 UMN Pharma Inc Rotavirus Infections Drug Product Portfolio
  18. 7.3.5 UMN Pharma Inc Recent Developments
  19. 7.4 Serum Institute of India Ltd
  20. 7.4.1 Serum Institute of India Ltd Company Information
  21. 7.4.2 Serum Institute of India Ltd Business Overview
  22. 7.4.3 Serum Institute of India Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Serum Institute of India Ltd Rotavirus Infections Drug Product Portfolio
  24. 7.4.5 Serum Institute of India Ltd Recent Developments
  25. 7.5 Nanotherapeutics Inc
  26. 7.5.1 Nanotherapeutics Inc Company Information
  27. 7.5.2 Nanotherapeutics Inc Business Overview
  28. 7.5.3 Nanotherapeutics Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Nanotherapeutics Inc Rotavirus Infections Drug Product Portfolio
  30. 7.5.5 Nanotherapeutics Inc Recent Developments
  31. 7.6 Medicago Inc
  32. 7.6.1 Medicago Inc Company Information
  33. 7.6.2 Medicago Inc Business Overview
  34. 7.6.3 Medicago Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Medicago Inc Rotavirus Infections Drug Product Portfolio
  36. 7.6.5 Medicago Inc Recent Developments
  37. 7.7 Curevac AG
  38. 7.7.1 Curevac AG Company Information
  39. 7.7.2 Curevac AG Business Overview
  40. 7.7.3 Curevac AG Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Curevac AG Rotavirus Infections Drug Product Portfolio
  42. 7.7.5 Curevac AG Recent Developments
  43. 7.8 Biological E Ltd
  44. 7.8.1 Biological E Ltd Company Information
  45. 7.8.2 Biological E Ltd Business Overview
  46. 7.8.3 Biological E Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biological E Ltd Rotavirus Infections Drug Product Portfolio
  48. 7.8.5 Biological E Ltd Recent Developments
  49. 7.9 Bharat Biotech International Ltd
  50. 7.9.1 Bharat Biotech International Ltd Company Information
  51. 7.9.2 Bharat Biotech International Ltd Business Overview
  52. 7.9.3 Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Bharat Biotech International Ltd Rotavirus Infections Drug Product Portfolio
  54. 7.9.5 Bharat Biotech International Ltd Recent Developments
8 North America
  1. 8.1 North America Rotavirus Infections Drug Market Size by Type
  2. 8.1.1 North America Rotavirus Infections Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Rotavirus Infections Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Rotavirus Infections Drug Price by Type (2021-2032)
  5. 8.2 North America Rotavirus Infections Drug Market Size by Application
  6. 8.2.1 North America Rotavirus Infections Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Rotavirus Infections Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Rotavirus Infections Drug Price by Application (2021-2032)
  9. 8.3 North America Rotavirus Infections Drug Market Size by Country
  10. 8.3.1 North America Rotavirus Infections Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Rotavirus Infections Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Rotavirus Infections Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Rotavirus Infections Drug Market Size by Type
  2. 9.1.1 Europe Rotavirus Infections Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Rotavirus Infections Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Rotavirus Infections Drug Price by Type (2021-2032)
  5. 9.2 Europe Rotavirus Infections Drug Market Size by Application
  6. 9.2.1 Europe Rotavirus Infections Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Rotavirus Infections Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Rotavirus Infections Drug Price by Application (2021-2032)
  9. 9.3 Europe Rotavirus Infections Drug Market Size by Country
  10. 9.3.1 Europe Rotavirus Infections Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Rotavirus Infections Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Rotavirus Infections Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Rotavirus Infections Drug Market Size by Type
  2. 10.1.1 China Rotavirus Infections Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Rotavirus Infections Drug Sales by Type (2021-2032)
  4. 10.1.3 China Rotavirus Infections Drug Price by Type (2021-2032)
  5. 10.2 China Rotavirus Infections Drug Market Size by Application
  6. 10.2.1 China Rotavirus Infections Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Rotavirus Infections Drug Sales by Application (2021-2032)
  8. 10.2.3 China Rotavirus Infections Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rotavirus Infections Drug Market Size by Type
  2. 11.1.1 Asia Rotavirus Infections Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Rotavirus Infections Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Rotavirus Infections Drug Price by Type (2021-2032)
  5. 11.2 Asia Rotavirus Infections Drug Market Size by Application
  6. 11.2.1 Asia Rotavirus Infections Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Rotavirus Infections Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Rotavirus Infections Drug Price by Application (2021-2032)
  9. 11.3 Asia Rotavirus Infections Drug Market Size by Country
  10. 11.3.1 Asia Rotavirus Infections Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Rotavirus Infections Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Rotavirus Infections Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rotavirus Infections Drug Market Size by Type
  2. 12.1.1 SAMEA Rotavirus Infections Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Rotavirus Infections Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Rotavirus Infections Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Rotavirus Infections Drug Market Size by Application
  6. 12.2.1 SAMEA Rotavirus Infections Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Rotavirus Infections Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Rotavirus Infections Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Rotavirus Infections Drug Market Size by Country
  10. 12.3.1 SAMEA Rotavirus Infections Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Rotavirus Infections Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Rotavirus Infections Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Rotavirus Infections Drug Value Chain Analysis
  2. 13.1.1 Rotavirus Infections Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Rotavirus Infections Drug Production Mode & Process
  6. 13.2 Rotavirus Infections Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Rotavirus Infections Drug Distributors
  9. 13.2.3 Rotavirus Infections Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst